New Sonic Foundry search engine finds words, phrases in video presentations
The Madison-based business is marketing the e...Sonic Foundry creates search engine for 7,000 expert video presentations
The site features direct links to presentations by users of the companys rich media software...InvestMidWest calls for business presentations
Dec. 16 is the early application deadline, and Jan. 13 is the final applic...BxVideo designs Web hosting service for Sonic Foundry media presentations
MADISON Rich media presentations created with s new suite of hosted services, which help organizations capture presentations digitally and publish them on the Web....Onchocerciasis: Presentation And Treatment
A disease called Onchocerciasis, river blindness or craw craw is endemic to Bioko Island, Equatorial Guinea. The disease presents as a weakening// in affected individuals thus rendering them listless and not fit for work. This in turn adversely impacts the economy of this area. The disease is caused by the worm Onchocerca volvulus and is transmitted through the bite of the black fly, Simu...Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Researchers have warned that routine pregnancy examinations to check a baby is in a good position before birth are not sensitive enough//. The researchers have explained that simple palpation, which is the feeling of the mother's bump could miss about 24 in 100 cases of abnormal lie, where in a baby is not in the normal head-down position. They further stated that it is very important...Rectangular Square Presentation Case
Description:A compact showcase unit. Made with tempered glass, one, two or three adjustable shelves, a door with a safety lock. Equipped with fluorescent lighting and levelers. Display is available in various sizes and cabinet finishes....Sygnis Pharma AG announces date for presentation of clinical results
HEIDELBERG, Germany, 11 July 2007 – On 23 July SYGNIS PharmaAG will present the results of the clinical phase IIa study forAX200 (AXIS-study). AX200, a compound for the treatment of stroke, is the mostadvanced drug candidate in SYGNIS’ product pipeline. Theprimary aim of the study is to show safety and tolerability ofAX200 in acute stroke patients. The results of the AXIS-stud...